Current Report Filing (8-k)
January 23 2023 - 8:31AM
Edgar (US Regulatory)
0001630212
false
0001630212
2023-01-20
2023-01-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January
20, 2023
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-38728 |
|
47-1685128 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
4400
Route 9 South, Suite 3100, Freehold, New Jersey 07728
(Address of principal executive offices) (zip code)
732-780-4400
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbols |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value per share |
|
ALBT |
|
The Nasdaq Capital Market |
Item
3.01 Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As
previously reported, on February 9, 2022, Avalon GloboCare Corp. (the "Company")
received a letter from the Listing Qualifications Staff (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq")
indicating that the bid price of the Company's common stock (the "Common Stock"), had closed below $1.00 per share
for 30 consecutive business days and, as a result, the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), which sets forth
the minimum bid price requirement for continued listing (the "Minimum Bid Requirement").
On
January 20, 2023, the Company received a letter from the Staff of Nasdaq indicating that it has regained compliance with the Minimum Bid
Requirement and this matter is now closed.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AVALON GLOBOCARE CORP. |
|
|
Dated: January 23, 2023 |
By: |
/s/ Luisa Ingargiola |
|
|
Name: |
Luisa Ingargiola |
|
|
Title: |
Chief Financial Officer |
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Aug 2023 to Aug 2024